Opioids are synthetic or natural agents that stimulate opioid receptors in the brain and nervous system and are often used to treat pain. However, the effects of the drugs can also lead to a high risk of substance abuse in some […]
Physicians highlight need for improved non-opioid treatments for opioid use disorder Read More »
The innovative epigenetic drugs space has witnessed a two-fold increase in Series A venture financing, with total deal value increasing from $172m in 2019 to $342m in 2024 year-to-date (YTD), according to GlobalData’s Pharma Intelligence Center Deals Database. In January
Epigenetic drugs show 375% increase in Series A venture financing in 2024 Read More »
The US Food and Drug Administration (FDA) has sent numerous warning letters to compounding pharmacies for illegally selling semaglutide and tirzepatide, or producing adulterated or misbranded versions. The FDA told the Washington Post that between August 2021 and mid-July 2024,
FDA warns Ozempic and Mounjaro counterfeit compounders Read More »
